Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease
AUTOR(ES)
Nicholson, Tricia
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=59676Documentos Relacionados
- Cost–utility analysis: Use QALYs only with great caution
- Cost-utility analysis of methylphenidate treatment for children and adolescents with ADHD in Brazil
- Retrospective cost-utility and budget impact assessments of Hypericum perforatum in contrast with Fluoxetine treatment for depression in Karachi, Pakistan
- Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm?
- Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil – comparison of outcomes from different static model types